American International Group, Inc. Graphite Bio, Inc. Transaction History

American International Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$2.24 - $2.66 $127 - $151	-57 Reduced 0.41%	13,929 $36,000
Q3 2023 Nov 13, 2023	BUY	$2.18 - $2.77 $1,085 - $1,379	498 Added 3.69%	13,986 $34,000
Q2 2023 Aug 04, 2023	BUY	$2.47 - $3.38 $33,315 - $45,589	13,488 New	13,488 $35,000
Q2 2022 Aug 12, 2022	SELL	$2.14 - $5.23 $31,363 - $76,650	-14,656 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$5.1 - $13.06 $30,701 - $78,621	6,020 Added 69.71%	14,656 $75,000
Q4 2021 Feb 11, 2022	SELL	$8.41 - $16.71 $2,161 - $4,294	-257 Reduced 2.89%	8,636 $107,000
Q3 2021 Nov 12, 2021	BUY	$15.81 - $28.39 $140,598 - $252,472	8,893 New	8,893 $146,000

637K

Ticker GRPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,211,200
Description
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.